2m 2m 2m 2m 2m 2m 2m
Coherus Onco (CHRS)
NASDAQ
$1.53+$0.06 (+4.01%)
Price as of Jul 14, 2026 8:37 AM EDT- $226.7MMarket Cap
- 54.79%1-Year Change
- BiotechnologyIndustry
Coherus Onco (CHRS)
$1.53+$0.06 (+4.01%)
CHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.47 | ||
Change | -$0.07 (-4.55%) | ||
Open | $1.50 | ||
High | $1.54 | ||
Low | $1.46 | ||
Previous Close | $1.54 | ||
Volume | 553,146 | ||
30-Day Average Volume | 1,133,229 | ||
1-Week Change | -5.77% | ||
1-Month Change | 5.00% | ||
1-Year Change | 54.79% | ||
3-Year Change | -65.57% | ||
5-Year Change | -88.96% | ||
Fundamentals | |||
Shares Outstanding | 154.2M | ||
Total Assets | $266.0M | ||
Market Cap | $226.7M | ||
Enterprise Value | $148.7M | ||
Period: QTR TTM FY | |||
Revenue | $12.3M | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$57.9M | ||
EBIT | -$36.1M | ||
EBITDA | -$35.3M | ||
Net Working Capital | $73.7M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | -5 | ||
PEG | -1 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue